임상정보
home > 글로벌제약산업정보> 의약품 R&D 정보> 임상정보
- 글자크기
IND Exemptions for Studies of Lawfully Marketed Drug or Biological Products for the Treatment of Cancer (FDA)
| 작성자 | 관리자 | ||
|---|---|---|---|
| 작성일 | 2018-05-24 | 조회수 | 1,848 |
| 국가정보 | 북 아메리카>미국 | ||
| 출처 | |||
| 원문 | https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm071717.pdf | ||
- 이전글 Investigational New Drug Applications (INDs)—Determining whether Human Research Studies can be conducted without an IND (FDA)
- 다음글 Expanded Access Web Site (FDA)
